Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
23 results
D1.202 - Small-Spotted Catshark Parvalbumin Sensitization in Fish-Allergic Patients
D1.203 - Pine Nut Allergy in a Pediatric Patient with Multiple Sensitizations to Tree Nuts and Storage Proteins
D1.204 - Pea-ling Back the Layers: A Systematic Review of Pea Allergies
D1.205 - Characterization of a cohort of fish allergic portuguese patients
D1.206 - A 50-year history of IgE-mediated hypersensitivity reactions to Saccharomyces cerevisiae presenting with respiratory symptoms
D1.207 - “Do nut know what: What is the current role of the prick test and serum IgE in the diagnosis of walnut allergy?
D1.208 - Clinical relevance of food allergen families
D1.209 - Pollen and Food Non-Specific Lipid Transfer Proteins: Clinical Presentations and Sensitization Profiles in a Mediterranean Population
D1.210 - Effects of Omalizumab on Human Basophils in Children with Cow’s Milk Protein Allergy
D1.212 - IgE mediated allergic reaction to rice
D1.213 - Exercise-Induced Anaphylaxis in a 18-Year-Old Woman with Egg Allergy and Potential Bird-Egg Syndrome
D1.214 - Food Allergy:Even in doubt, Challenge Test
D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data
D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases
D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin
D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity
D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis
D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes
D3.416 - Hereditary Alpha-Tryptasemia: A Case Series
D3.417 - "Comprehensive Allergological Evaluation and Management of Severe Anaphylaxis to Vespid Venoms: A Case Study"
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download